Search

Search Constraints

You searched for: Author/Creator Wildt, Signe

Search Results

2. Vedolizumab as first-line biological therapy in elderly patients and those with contraindications for anti-TNF therapy: a real-world, nationwide cohort of patients with inflammatory bowel diseases. (2nd September 2021)

3. Vedolizumab clearance in neonates, susceptibility to infections and developmental milestones: a prospective multicentre population‐based cohort study. Issue 10 (2nd September 2021)

5. Anti-TNF Therapy in Pregnant Women With Inflammatory Bowel Disease: Effects of Therapeutic Strategies on Disease Behavior and Birth Outcomes. Issue 1 (29th May 2019)

7. The Process of Developing a Disease Activity Index in Microscopic Colitis. (25th September 2021)

8. Biochemical Diagnosis of Bile Acid Diarrhea: Prospective Comparison With the 75Seleno-Taurohomocholic Acid Test. (29th December 2020)

9. European guidelines on microscopic colitis: United European Gastroenterology and European Microscopic Colitis Group statements and recommendations. Issue 1 (22nd February 2021)

10. Fecal Calprotectin Is Not Affected by Pregnancy: Clinical Implications for the Management of Pregnant Patients with Inflammatory Bowel Disease. Issue 7 (11th May 2017)